Specifically, miR-181a was necessary, but not sufficient, to promote tumor invasion in response to TGF-β by enhancing phosphorylation of SRC, AKT, and ERK 1/2, without affecting proliferation [10]. The gene discussed is TGFB1; the disease is neoplasm.